文献
J-GLOBAL ID:202202262827082253
整理番号:22A0215035
非ランダム化研究は新しい医療治療の有効性または安全性に関する妥当な推論を支援できるか?【JST・京大機械翻訳】
When Can Nonrandomized Studies Support Valid Inference Regarding Effectiveness or Safety of New Medical Treatments?
著者 (10件):
Franklin Jessica M.
(Optum Epidemiology, Boston, Massachusetts, USA)
,
Franklin Jessica M.
(Division of Pharmacoepidemiology & Pharmacoeconomics, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA)
,
Platt Richard
(Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, Massachusetts, USA)
,
Dreyer Nancy A.
(IQVIA Real World Solutions, Cambridge, Massachusetts, USA)
,
London Alex John
(Philosophy Department & Center for Ethics and Policy, Carnegie Mellon University, Pittsburgh, Pennsylvania, USA)
,
Simon Gregory E.
(Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA)
,
Watanabe Jonathan H.
(School of Pharmacy and Pharmaceutical Sciences, University of California Irvine, Irvine, California, USA)
,
Horberg Michael
(Kaiser Permanente Mid-Atlantic Permanente Research Institute and Mid-Atlantic Permanente Medical Group, Bethesda, Maryland, USA)
,
Hernandez Adrian
(Duke Clinical Research Institute, Durham, North Carolina, USA)
,
Califf Robert M.
(Verily Life Sciences and Google Health, Cambridge, Massachusetts, USA)
資料名:
Clinical Pharmacology & Therapeutics
(Clinical Pharmacology & Therapeutics)
巻:
111
号:
1
ページ:
108-115
発行年:
2022年
JST資料番号:
A0721B
ISSN:
0009-9236
資料種別:
逐次刊行物 (A)
記事区分:
文献レビュー
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)